Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Librera OncoLink / Revisiones de Libros, Música y Videos
John Han-Chih Chang, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de noviembre del 2001
![]() | Editors: Joji Utsunomiya, John J. Mulvihill, Walter Weber
Publisher: John Wiley and Sons, Inc., May 1999 ISBN: 0-471-24937-8 OncoLink Rating: |
This book was inspired by the UICC (International Union Against Cancer) Symposium on Familial Cancer and Prevention, held in Kobe, Japan in 1997. Health specialists, representing many different specialties, came from all over the world to discuss the latest research in their fight against cancer. The focus of the symposium was the new weapon in treating and perhaps preventing cancer: knowledge of a person's family history and genetics. This book, written by many contributors, summarizes that effort.
The book is divided into five sections. In the first section, entitled "Overviews," several contributors describe what they feel the focus of the symposium is. This is best summarized by Walter Weber, who states: "The aims of the UICC Familial Cancer and Prevention Project are to promote the use of the family history for cancer control by sharing information; examining controllable causative factors; encouraging genetic-epidemiologic; preventive, and therapeutic research; and discussing ethical, legal, economic, and psychosocial aspects."
The second section is entitled "General Strategies and Experience," and is subdivided into discussions of logistics and counseling issues. The articles pertaining to logistics argue the importance of setting up an international standard questionnaire for doctors to use with their patients, hence facilitating the ability to collect worldwide data. The contributors discuss the development of software known as Progeny to aid in the data collection. They also provide several examples where this familial data collection is already in use, such as The National Neurofibromatosis Foundation in the United States, and the Swiss medical system. The articles pertaining to the counseling issues discuss ethical questions such as the right to know, patient confidentiality, etc.
The third section is by far the largest, and discusses specific familial cancers, such as endocrine and breast cancer, and many more. These articles cover the latest findings in mostly clinical, but also molecular research. They even touch on prevention issues (ideas such as diet, aspirin use, and calcium intake are discussed).
The last two sections are quite short. Section four is entitled "Workshop Reports," and briefly summarizes the entire symposium's presenting speakers. The fifth section, entitled "Poster Sessions," provides the titles and authors of the presenting posters.
This book is valuable to anyone interested in the use of genetics and epidemiology in the fight against cancer. It is not intended for the layperson, as it is very technically and medically oriented. It compiles much valuable research, and would be of value to anyone in the cancer field, whether it is in a research or clinical capacity.
Quitting smoking after a cancer diagnosis has many benefits for the patient. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

